Skip to main content

Advertisement

Log in

Sodium Butyrate Ameliorates Atopic Dermatitis-Induced Inflammation by Inhibiting HDAC3-Mediated STAT1 and NF-κB Pathway

  • RESEARCH
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

A topic dermatitis (AD) is a common chronic and recurrent skin disorder. The protective effects of sodium butyrate (NaB), a metabolite of short-chain fatty acid breakdown by the gut microbiota, have been widely reported in numerous inflammatory diseases. However, the effect of NaB treatment alone on AD has not been reported. In the current study, AD was induced in BALB/c mice with 2,4-dinitrochlorobenzene (DNCB) for 28 days with NaB (200 mg/kg) treatment by gavage. NaB attenuated AD-induced skin bleeding, scarring, dryness, abrasions and erosions. In addition, NaB inhibited inflammatory cells infiltration and attenuated the expression of inflammatory cytokines and chemokines. Mechanistically, NaB reduced histone deacetylase 3 (HDAC3) expression and NF-κB p65 nuclear translocation by increasing the lysine acetylation levels of STAT1 and NF-κB p65 in AD. Taken together, our study suggests that NaB inhibits inflammatory mediators and ameliorates AD by inhibiting HDAC3 expression, thereby upregulating STAT1 and NF-κB p65 lysine acetylation levels and reducing NF-κB p65 nuclear translocation. Therefore, this study provides a new theoretical basis for NaB in the treatment of AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of Data and Materials

The dataset supporting the conclusions of this article is included within the article.

References

  1. Lloyd-Lavery, A., L. Solman, D.J.C. Grindlay, N.K. Rogers, K.S. Thomas, and K.E. Harman. 2019. What’s new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors. Clinical and Experimental Dermatology 44 (4): 370–375. https://doi.org/10.1111/ced.13853.

  2. Langan, S.M., A.D. Irvine, and S. Weidinger. 2020. Atopic dermatitis. The Lancet 396: 345–360. https://doi.org/10.1016/S0140-6736(20)31286-1.

    Article  CAS  Google Scholar 

  3. Silverberg, J.I., J.M. Gelfand, D.J. Margolis, M. Boguniewicz, L. Fonacier, M.H. Grayson, et al. 2018. Patient burden and quality of life in atopic dermatitis in US adults. Annals of Allergy, Asthma & Immunology 121: 340–347. https://doi.org/10.1016/j.anai.2018.07.006.

    Article  Google Scholar 

  4. Chrostowska-Plak, D., A. Reich, and J.C. Szepietowski. 2013. Relationship between itch and psychological status of patients with atopic dermatitis: Itch in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 27: e239–e242. https://doi.org/10.1111/j.1468-3083.2012.04578.x.

    Article  PubMed  CAS  Google Scholar 

  5. Simpson, E.L., M. Bruin-Weller, C. Flohr, M.R. Ardern-Jones, S. Barbarot, M. Deleuran, et al. 2017. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. Journal of the American Academy of Dermatology 77: 623–633. https://doi.org/10.1016/j.jaad.2017.06.042.

    Article  PubMed  Google Scholar 

  6. Louis, P., and H.J. Flint. 2017. Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology 19: 29–41. https://doi.org/10.1111/1462-2920.13589.

    Article  PubMed  CAS  Google Scholar 

  7. Kaźmierczak-Siedlecka, K., K. Skonieczna-Żydecka, T. Hupp, R. Duchnowska, N. Marek-Trzonkowska, and K. Połom. 2022. Next-generation probiotics – do they open new therapeutic strategies for cancer patients? Gut Microbes 14: 2035659. https://doi.org/10.1080/19490976.2022.2035659.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Liu, H., J. Wang, T. He, S. Becker, G. Zhang, D. Li, et al. 2018. Butyrate: a double-edged sword for health? Advances in Nutrition 9: 21–29. https://doi.org/10.1093/advances/nmx009.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Patnala, R., T.V. Arumugam, N. Gupta, and S.T. Dheen. 2017. HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke. Molecular Neurobiology 54: 6391–6411. https://doi.org/10.1007/s12035-016-0149-z.

    Article  PubMed  CAS  Google Scholar 

  10. Wang, J., L. Wen, Y. Wang, and F. Chen. 2016. Therapeutic effect of histone deacetylase inhibitor, sodium butyrate, on allergic rhinitis in vivo. DNA and Cell Biology 35: 203–208. https://doi.org/10.1089/dna.2015.3037.

    Article  PubMed  CAS  Google Scholar 

  11. Traisaeng, S., D.R. Herr, H.-J. Kao, T.-H. Chuang, and C.-M. Huang. 2019. A derivative of butyric acid, the fermentation metabolite of staphylococcus epidermidis, inhibits the growth of a staphylococcus aureus strain isolated from atopic dermatitis patients. Toxins 11: 311. https://doi.org/10.3390/toxins11060311.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Kim, J.A., S.-H. Kim, I.S. Kim, D.Y. Yu, S.C. Kim, S.H. Lee, et al. 2018. Anti-inflammatory effects of a mixture of lactic acid bacteria and sodium butyrate in atopic dermatitis murine model. Journal of Medicinal Food 21: 716–725. https://doi.org/10.1089/jmf.2017.4116.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Zeng, H.R., B. Zhao, X. Rui, G.H. Jia, Y. Wu, D. Zhang, et al. 2021. A TCM formula VYAC ameliorates DNCB-induced atopic dermatitis via blocking mast cell degranulation and suppressing NF-κB pathway. Journal of Ethnopharmacology 280: 114454. https://doi.org/10.1016/j.jep.2021.114454.

    Article  PubMed  CAS  Google Scholar 

  14. Torella, D., A. Curcio, C. Gasparri, V. Galuppo, D.D. Serio, F.C. Surace, et al. 2007. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation. American Journal of Physiology-Heart and Circulatory Physiology 292: H2935–H2943. https://doi.org/10.1152/ajpheart.00887.2006.

    Article  PubMed  CAS  Google Scholar 

  15. Zhou, D., Q. Pan, F.-Z. Xin, R.-N. Zhang, C.-X. He, G.-Y. Chen, et al. 2017. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World Journal of Gastroenterology 23: 60–75. https://doi.org/10.3748/wjg.v23.i1.60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Wang, Y., L. Tan, K. Jiao, C. Xue, Q. Tang, S. Jiang, et al. 2022. Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels. British Journal of Pharmacology 179: 4792–4808. https://doi.org/10.1111/bph.15913.

    Article  PubMed  CAS  Google Scholar 

  17. Lee, Y., H.K. Choi, K.P.U. N’deh, Y.-J. Choi, M. Fan, E.-K. Kim, et al. 2020. Inhibitory effect of Centella asiatica extract on DNCB-induced atopic dermatitis in HaCaT cells and BALB/c mice. Nutrients 12: 411. https://doi.org/10.3390/nu12020411.

  18. Valvassori, S.S., G.C. Dal-Pont, A.V. Steckert, R.B. Varela, J. Lopes-Borges, E. Mariot, et al. 2016. Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain. Psychiatry Research 235: 154–159. https://doi.org/10.1016/j.psychres.2015.11.017.

    Article  PubMed  CAS  Google Scholar 

  19. Han, L., W. Su, J. Huang, J. Zhou, S. Qiu, and D. Liang. 2014. Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms. PLoS ONE 9: e108931. https://doi.org/10.1371/journal.pone.0108931.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Risitano, R., M. Currò, S. Cirmi, N. Ferlazzo, P. Campiglia, D. Caccamo, et al. 2014. Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes. PLoS ONE 9: e107431. https://doi.org/10.1371/journal.pone.0107431.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Huang, S.-E., E. Sulistyowati, Y.-Y. Chao, B.-N. Wu, Z.-K. Dai, J.-H. Hsu, et al. 2021. In vitro evaluation of the anti-inflammatory effect of KMUP-1 and in vivo analysis of its therapeutic potential in osteoarthritis. Biomedicines 9: 615. https://doi.org/10.3390/biomedicines9060615.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Kumar, P., V.R. Gogulamudi, R. Periasamy, G. Raghavaraju, U. Subramanian, and K.N. Pandey. 2017. Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice. American Journal of Physiology Renal Physiology 313: F781–F795. https://doi.org/10.1152/ajprenal.00166.2017.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Chen, S., J. Ye, X. Chen, J. Shi, W. Wu, W. Lin, et al. 2018. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3. Journal of Neuroinflammation 15: 150. https://doi.org/10.1186/s12974-018-1193-6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Chovatiya, R. 2023. Atopic dermatitis (Eczema). Journal of the American Medical Association 329: 268. https://doi.org/10.1001/jama.2022.21457.

    Article  PubMed  Google Scholar 

  25. Hay, R.J., N.E. Johns, H.C. Williams, I.W. Bolliger, R.P. Dellavalle, D.J. Margolis, et al. 2014. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. The Journal of Investigative Dermatology 134: 1527–1534. https://doi.org/10.1038/jid.2013.446.

    Article  PubMed  CAS  Google Scholar 

  26. Chen, G., X. Ran, B. Li, Y. Li, D. He, B. Huang, et al. 2018. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. eBioMedicine 30: 317–325. https://doi.org/10.1016/j.ebiom.2018.03.030.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Das, P., P. Mounika, M.L. Yellurkar, V.S. Prasanna, S. Sarkar, R. Velayutham, et al. 2022. Keratinocytes: an enigmatic factor in atopic dermatitis. Cells 11: 1683. https://doi.org/10.3390/cells11101683.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Weidinger, S., L.A. Beck, T. Bieber, K. Kabashima, and A.D. Irvine. 2018. Atopic dermatitis. Nature Reviews Disease Primers 4: 1. https://doi.org/10.1038/s41572-018-0001-z.

    Article  PubMed  Google Scholar 

  29. Renert-Yuval, Y., J.P. Thyssen, R. Bissonnette, T. Bieber, K. Kabashima, D. Hijnen, et al. 2021. Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council. The Journal of Allergy and Clinical Immunology 147: 1174–1190.e1. https://doi.org/10.1016/j.jaci.2021.01.013.

    Article  PubMed  CAS  Google Scholar 

  30. Wang, W., F. Xiao, P. Wan, P. Pan, Y. Zhang, F. Liu, et al. 2017. EV71 3D protein binds with NLRP3 and enhances the assembly of inflammasome complex. PLoS Pathogens 13: e1006123. https://doi.org/10.1371/journal.ppat.1006123.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Hoesel, B., and J.A. Schmid. 2013. The complexity of NF-κB signaling in inflammation and cancer. Molecular Cancer 12: 86. https://doi.org/10.1186/1476-4598-12-86.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Yu, H., L. Lin, Z. Zhang, H. Zhang, and H. Hu. 2020. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduction and Targeted Therapy 5: 209. https://doi.org/10.1038/s41392-020-00312-6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Jiang, X., M. Yu, Y. Ou, Y. Cao, Y. Yao, P. Cai, et al. 2017. Downregulation of USP4 promotes activation of microglia and subsequent neuronal inflammation in rat spinal cord after injury. Neurochemical Research 42: 3245–3253. https://doi.org/10.1007/s11064-017-2361-2.

    Article  PubMed  CAS  Google Scholar 

  34. Wang, G., Y. Shi, X. Jiang, R.K. Leak, X. Hu, Y. Wu, et al. 2015. HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis. Proceedings of the National Academy of Sciences 112: 2853–2858. https://doi.org/10.1073/pnas.1501441112.

    Article  CAS  Google Scholar 

  35. Islam, R., D. Dash, and R. Singh. 2022. Intranasal curcumin and sodium butyrate modulates airway inflammation and fibrosis via HDAC inhibition in allergic asthma. Cytokine 149: 155720. https://doi.org/10.1016/j.cyto.2021.155720.

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This study was funded by the Natural Science Foundation of Chongqing, China (No. cstc2020jcyj-bshX0110), and the Foundation of Medical Science and Technology Innovation of Chongqing general hospital, China (No. 2019ZDXM02).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Wei Zhou, Dan Zeng; Methodology: Chaoqun Hu, Yunxia Huang, Shunan Liu; Validation: Wei Zhou, Chaoqun Hu, Qian Deng; Formal analysis: Wei Zhou, Chaoqun Hu, Qian Deng; Writing-Original Draft: Wei Zhou; Writing-Review & Editing: Chaoqun Hu, Weikang Zhou, Dan Zeng; Funding acquisition: Wei Zhou. All authors have read and agreed to the final version of the manuscript.

Corresponding author

Correspondence to Wei Zhou.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

10753_2023_1955_MOESM1_ESM.tif

Supplementary Figure 1. A No obvious effect of NaB on cell viability of HaCaT cells, indicated by CCK-8 assay (Veh: vehicle, NaB: Sodium Butyrate, n = 6). B NaB preserved the viability of TNF-α/IFN-γ-treated HaCaT cells in a dose-dependent manner, reflected by CCK-8 assay (n = 6, *P < 0.05 vs Control group, #P < 0.05 vs TNF-α/IFN-γ (10 ng/mL) group) (TIF 929 KB)

Supplementary file2 (XLSX 9 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, C., Zeng, D., Huang, Y. et al. Sodium Butyrate Ameliorates Atopic Dermatitis-Induced Inflammation by Inhibiting HDAC3-Mediated STAT1 and NF-κB Pathway. Inflammation (2023). https://doi.org/10.1007/s10753-023-01955-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10753-023-01955-7

KEY WORDS

Navigation